Your browser doesn't support javascript.
loading
Whole-genome sequence-informed MALDI-TOF MS diagnostics reveal importance of Klebsiella oxytoca group in invasive infections: a retrospective clinical study.
Cuénod, Aline; Wüthrich, Daniel; Seth-Smith, Helena M B; Ott, Chantal; Gehringer, Christian; Foucault, Frédéric; Mouchet, Roxanne; Kassim, Ali; Revathi, Gunturu; Vogt, Deborah R; von Felten, Stefanie; Bassetti, Stefano; Tschudin-Sutter, Sarah; Hettich, Timm; Schlotterbeck, Götz; Homberger, Christina; Casanova, Carlo; Moran-Gilad, Jacob; Sagi, Orli; Rodríguez-Sánchez, Belén; Müller, Franco; Aerni, Martina; Gaia, Valeria; van Dessel, Helke; Kampinga, Greetje A; Müller, Claudia; Daubenberger, Claudia; Pflüger, Valentin; Egli, Adrian.
  • Cuénod A; Applied Microbiology Research, Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031, Basel, Switzerland. aline.cuenod@stud.unibas.ch.
  • Wüthrich D; Division of Clinical Bacteriology and Mycology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland. aline.cuenod@stud.unibas.ch.
  • Seth-Smith HMB; Applied Microbiology Research, Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031, Basel, Switzerland.
  • Ott C; Division of Clinical Bacteriology and Mycology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
  • Gehringer C; Swiss Institute for Bioinformatics, Basel, Switzerland.
  • Foucault F; Applied Microbiology Research, Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031, Basel, Switzerland.
  • Mouchet R; Division of Clinical Bacteriology and Mycology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
  • Kassim A; Swiss Institute for Bioinformatics, Basel, Switzerland.
  • Revathi G; Applied Microbiology Research, Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031, Basel, Switzerland.
  • Vogt DR; Division of Clinical Bacteriology and Mycology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
  • von Felten S; Applied Microbiology Research, Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031, Basel, Switzerland.
  • Bassetti S; Division of Clinical Bacteriology and Mycology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
  • Tschudin-Sutter S; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • Hettich T; Mabritec AG, Riehen, Switzerland.
  • Schlotterbeck G; Mabritec AG, Riehen, Switzerland.
  • Homberger C; Aga Khan University Hospital, Nairobi, Kenya.
  • Casanova C; Aga Khan University Hospital, Nairobi, Kenya.
  • Moran-Gilad J; Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland.
  • Sagi O; Department of Clinical Research, University of Basel and University Hospital Basel, Basel, Switzerland.
  • Rodríguez-Sánchez B; Department of Biostatistics, Epidemiology, Biostatistics and Prevention Institute (EBPI), University of Zurich, Zurich, Switzerland.
  • Müller F; Division of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • Aerni M; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland.
  • Gaia V; Department of Clinical Research, University of Basel, Basel, Switzerland.
  • van Dessel H; Division of Instrumental Analytics, School of Applied Sciences (FHNW), Muttenz, Switzerland.
  • Kampinga GA; Division of Instrumental Analytics, School of Applied Sciences (FHNW), Muttenz, Switzerland.
  • Müller C; Applied Microbiology Research, Department of Biomedicine, University of Basel, Hebelstrasse 20, 4031, Basel, Switzerland.
  • Daubenberger C; Division of Clinical Bacteriology and Mycology, University Hospital Basel, Petersgraben 4, 4031, Basel, Switzerland.
  • Pflüger V; Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
  • Egli A; Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Genome Med ; 13(1): 150, 2021 09 13.
Article en En | MEDLINE | ID: mdl-34517886
ABSTRACT

BACKGROUND:

Klebsiella spp. are opportunistic pathogens which can cause severe infections, are often multi-drug resistant and are a common cause of hospital-acquired infections. Multiple new Klebsiella species have recently been described, yet their clinical impact and antibiotic resistance profiles are largely unknown. We aimed to explore Klebsiella group- and species-specific clinical impact, antimicrobial resistance (AMR) and virulence.

METHODS:

We analysed whole-genome sequence data of a diverse selection of Klebsiella spp. isolates and identified resistance and virulence factors. Using the genomes of 3594 Klebsiella isolates, we predicted the masses of 56 ribosomal subunit proteins and identified species-specific marker masses. We then re-analysed over 22,000 Matrix-Assisted Laser Desorption Ionization - Time Of Flight (MALDI-TOF) mass spectra routinely acquired at eight healthcare institutions in four countries looking for these species-specific markers. Analyses of clinical and microbiological endpoints from a subset of 957 patients with infections from Klebsiella species were performed using generalized linear mixed-effects models.

RESULTS:

Our comparative genomic analysis shows group- and species-specific trends in accessory genome composition. With the identified species-specific marker masses, eight Klebsiella species can be distinguished using MALDI-TOF MS. We identified K. pneumoniae (71.2%; n = 12,523), K. quasipneumoniae (3.3%; n = 575), K. variicola (9.8%; n = 1717), "K. quasivariicola" (0.3%; n = 52), K. oxytoca (8.2%; n = 1445), K. michiganensis (4.8%; n = 836), K. grimontii (2.4%; n = 425) and K. huaxensis (0.1%; n = 12). Isolates belonging to the K. oxytoca group, which includes the species K. oxytoca, K. michiganensis and K. grimontii, were less often resistant to 4th-generation cephalosporins than isolates of the K. pneumoniae group, which includes the species K. pneumoniae, K. quasipneumoniae, K. variicola and "K. quasivariicola" (odds ratio = 0.17, p < 0.001, 95% confidence interval [0.09,0.28]). Within the K. pneumoniae group, isolates identified as K. pneumoniae were more often resistant to 4th-generation cephalosporins than K. variicola isolates (odds ratio = 2.61, p = 0.003, 95% confidence interval [1.38,5.06]). K. oxytoca group isolates were found to be more likely associated with invasive infection to primary sterile sites than K. pneumoniae group isolates (odds ratio = 2.39, p = 0.0044, 95% confidence interval [1.05,5.53]).

CONCLUSIONS:

Currently misdiagnosed Klebsiella spp. can be distinguished using a ribosomal marker-based approach for MALDI-TOF MS. Klebsiella groups and species differed in AMR profiles, and in their association with invasive infection, highlighting the importance for species identification to enable effective treatment options.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Klebsiella / Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción / Klebsiella oxytoca / Secuenciación Completa del Genoma Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Klebsiella / Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción / Klebsiella oxytoca / Secuenciación Completa del Genoma Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Año: 2021 Tipo del documento: Article